Jeffrey L. Wade - Jun 20, 2023 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
President and CFO
Signature
/s/ Jeffrey L. Wade
Stock symbol
LXRX
Transactions as of
Jun 20, 2023
Transactions value $
$28,000
Form type
4
Date filed
6/20/2023, 04:10 PM
Previous filing
Mar 1, 2023
Next filing
Sep 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Purchase $23.4K +10K +4.13% $2.34 252K Jun 20, 2023 Direct
transaction LXRX Common Stock Purchase $4.65K +2K +0.79% $2.33 254K Jun 20, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.